Amgen News

This report updates the previous North American biotechnology report, focusing on the markets in Canada and the United States.

Developing a game plan when investing in healthcare can be a daunting task. Searching for intrinsic value between pharmaceutical makers, biotechnology companies and healthcare providers can lead investor to ...

Pressure BioSciences, Inc. today provided an update on various corporate activities, including the presentation of favorable data generated by scientists at Amgen, Inc.

RDATE:01102008 Boston, MA -- Airspan Networks Inc. ; Amgen Inc., TheWallStreetLeader.com is part of Stock Profiler.US, LLC's News Division.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Thousand Oaks-based Amgen Inc. reported Thursday that the U.S. District Court in Boston upheld a prior jury verdict that a competitor's drug infringes on its patents and ruled that Amgen is entitled to a ...

Maguire Properties Inc., downtown Los Angeles' largest office landlord, said its board designated former Amgen Inc.

A year after a jury ruled that F. Hoffmann-La Roche Ltd.'s PEGylated erythropoietin product, Mircera, infringed four of Amgen Inc.'s EPO patents, a District Court judge issued a decision upholding that verdict ...

THOUSAND OAKS, Calif. - Amgen announced today that the United States District Court in Boston issued its written decision upholding the prior jury verdict and court rulings regarding the infringement, validity ...

Roche Holding AG , the world's biggest maker of cancer medicines, can't sell the anemia drug Mircera in the U.S. because it infringes patents owned by Amgen Inc.

Lost in a sea of inversely charged exchange traded funds that have reaped the benefits of carnage in indexes invested overseas, in materials, chips and myriad other areas, a handful of health care funds are ...

Amgen has submitted the executive summary to regulatory authorities, including the U.S. Food and Drug Administration and the European Medicines Agency .

Cutbacks amid tough times in 2007 have scuttled Amgen Inc. 's plan to move hundreds of administrative jobs from California to Longmont.

Dave Bengston, VP of Colorado operations at Amgen, stands between two cell culture bioreactors at the company's Boulder plant.

U.S. regulators said they're reviewing whether tests of anemia drugs made by Amgen Inc.

US regulators said they're reviewing whether tests of anemia drugs from Amgen Inc.

U.S. health officials said on Friday they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a German study of stroke patients.

FDA reviews experimental use of anemia drugs Comments WASHINGTON - Federal health regulators said Friday they are reviewing an experimental use of blockbuster anemia drugs made by Amgen and Johnson & Johnson ...

Ariad Pharmaceuticals Inc. , an oncology-focused drug developer in Cambridge, lost its patent case against Amgen Inc., Ariad officials reported.

Analyzing companies for potential investment is fun, profitable, and educational.